Description

OSSOTIDE Injection (GUSHU) is a sterile injectable bone peptide preparation developed to assist in the treatment of orthopedic conditions such as fractures, osteoporosis, and degenerative joint diseases. Its mechanism involves stimulating osteoblast proliferation, promoting collagen synthesis, and enhancing calcium deposition in the bone matrix.

Each 2ml vial contains 10mg of purified bone-derived polypeptides. OSSOTIDE has been widely adopted in hospitals and clinics throughout China and is backed by both in vivo and clinical research.

Manufactured by Nanjing Xinbai Pharmaceutical Co., Ltd., the formulation is certified under Chinese NMPA approval H20003533 and is distributed in tamper-proof boxes of 10 vials.

?? This product is approved for clinical use in China. Please consult your country’s local regulatory framework before use.

Product Specifications

Mechanism & Clinical Applications

OSSOTIDE Injection acts by:

• Stimulating osteoblast differentiation

• Enhancing synthesis of Type I collagen

• Promoting calcium and phosphate mineralization

• Speeding up healing of fractures and bone defects

Clinical Applications:

• Osteoporosis (post-menopausal or age-related)

• Non-union or delayed-union fractures

• Osteoarthritis and joint degeneration

• Post-surgical bone recovery

• Spinal fusion, bone graft integration

Known Reactions (Clinical Setting)

In human use under physician guidance, OSSOTIDE has been associated with:

• Mild localized pain at the injection site

• Rare allergic skin reactions

• Transient serum calcium changes (monitoring recommended)

Always follow local clinical protocol and consult a healthcare provider.

Safety & Handling Guidelines

• Prescription Required: Yes

• Administration: Intramuscular or intravenous only under medical supervision

• Storage: Refrigerate 2–8°C

• Disposal: Treat as biohazard material according to local regulations

Core Keywords

• ossotide injection

• GUSHU bone peptide

• ossotide 10mg 2ml

• fracture healing peptide

• osteoporosis injectable peptide

• Nanjing Xinbai ossotide

• H20003533 ossotide

• bone regeneration injection

• bone matrix peptide

• osteoblast peptide treatment

Packaging & Supply Notes

• Package Configuration: 10 single-dose vials per box

• Shipping Compliance: Cold-chain shipping supported

• Customs & Regulations: Buyer is responsible for compliance with import regulations. Contact us for assistance.

Regulatory Notice

This product is approved for human clinical use in China. Outside China, it may be subject to regulatory limitations. It is not FDA-approved for clinical use in the US or EU. Ensure compliance with your local health authority before purchase or administration.